# APOO

## Overview
The APOO gene encodes the protein apolipoprotein O, which is a member of the apolipoprotein family involved in lipid metabolism and mitochondrial function. Apolipoprotein O is primarily associated with high-density lipoproteins (HDL) and plays a significant role in lipid transport and energy homeostasis. As a mitochondrial protein, it is involved in oxidative phosphorylation and the regulation of reactive oxygen species (ROS) production, thereby influencing cellular energy balance and metabolic processes (Turkieh2014Apolipoprotein; Weijler2018Oleic). The protein is also a component of the mitochondrial contact site and organizing system (MICOS) complex, which is essential for maintaining mitochondrial architecture (Koob2015The). Mutations in the APOO gene have been linked to cardiovascular and metabolic disorders, highlighting its clinical significance in conditions such as diabetic cardiomyopathy and atherosclerosis (Chen2024Apolipoprotein; Turkieh2014Apolipoprotein).

## Structure
Apolipoprotein O (APOO) is a protein encoded by the APOO gene, characterized by a 198-amino acid peptide sequence that is conserved across species (Turkieh2014Apolipoprotein). The primary structure of APOO includes a slightly negatively charged N-terminus and exhibits medium overall hydrophobicity (Turkieh2014Apolipoprotein). APOO shares a homologous domain sequence with other apolipoproteins such as A1, A-IV, and E, indicating a potential similarity in function or structure (Weijler2018Oleic).

APOO is known to be a mitochondrial protein, localizing within the mitochondria and playing a role in mitochondrial function and lipid metabolism (Weijler2018Oleic; Turkieh2014Apolipoprotein). It is primarily found in the bloodstream on high-density lipoproteins (Turkieh2014Apolipoprotein). The protein is identified as a mature O-glycosylated protein, with a molecular weight of approximately 55 kDa, as observed in Western blot analyses (Weijler2018Oleic).

While specific details on the secondary, tertiary, and quaternary structures of APOO are not provided, its role in mitochondrial morphology and function suggests a complex structure that may involve interactions with other mitochondrial proteins (Turkieh2014Apolipoprotein). The presence of splice variants or isoforms is not detailed in the available context.

## Function
Apolipoprotein O (APOO) is a protein involved in lipid metabolism and mitochondrial function. It is associated with high-density lipoproteins (HDL) and plays a role in lipid transport and energy homeostasis. In healthy human cells, APOO is active in the mitochondria, where it influences oxidative phosphorylation and reactive oxygen species (ROS) production, impacting cellular energy balance and metabolic processes (Turkieh2014Apolipoprotein; Weijler2018Oleic).

APOO is implicated in the regulation of cholesterol metabolism. It affects cholesterol homeostasis by modulating the saturation of fatty acyl chains in phosphatidylcholine (PC), which influences cholesterol clearance (Chen2024Apolipoprotein). APOO also promotes cholesterol efflux from macrophage cells, similar to the effect of apolipoprotein A1 (apoA1), suggesting a role in cholesterol transport (Lamant2006ApoO).

In terms of mitochondrial function, APOO is involved in mitochondrial uncoupling, which may protect the mitochondrial matrix against lipid-induced and ROS-mediated damage (Weijler2018Oleic). This uncoupling is thought to modulate ROS production, potentially influencing metabolic-induced oxidative stress (Weijler2018Oleic). APOO's role in these processes highlights its importance in maintaining cellular homeostasis and energy regulation.

## Clinical Significance
Mutations and alterations in the expression of the APOO gene have been linked to several cardiovascular and metabolic conditions. Overexpression of APOO is associated with mitochondrial dysfunction and heart dysfunction, particularly in the context of diabetic cardiomyopathy. This overexpression leads to mitochondrial uncoupling, increased fatty acid metabolism, and reactive oxygen species (ROS) production, resulting in lipotoxicity and lipoapoptosis in cardiomyocytes (Turkieh2014Apolipoprotein). In transgenic mice, high levels of APOO expression correlate with depressed ventricular function and structural changes in the heart, such as myofibrillar disarray and mitochondrial degeneration (Turkieh2014Apolipoprotein).

APOO is also implicated in cholesterol metabolism, where its deficiency can lead to increased plasma cholesterol levels and more severe atherosclerotic lesions. This is due to its role in regulating lipid metabolism independently of the low-density lipoprotein receptor (LDLR) and apolipoprotein E (APOE) (Chen2024Apolipoprotein). APOO deficiency affects phospholipid unsaturation and cholesterol excretion, contributing to hypercholesterolemia and atherosclerosis (Chen2024Apolipoprotein). These findings suggest that APOO could be a potential target for managing conditions like atherosclerosis and diabetic cardiomyopathy.

## Interactions
APOO, also known as MIC26, is a component of the mitochondrial contact site and organizing system (MICOS) complex, which is crucial for maintaining mitochondrial architecture. The non-glycosylated 22 kDa isoform of MIC26 interacts physically with several subunits of the MICOS complex, including MIC60, MIC27, and MIC10, suggesting its role as a novel constituent of this complex (Koob2015The). These interactions are important for the formation of crista junctions within mitochondria, which are essential for mitochondrial membrane architecture and function (Koob2015The).

A mutation in the APOO gene, specifically the c.350T>C pathogenic variant (p.I117T in MIC26), affects the MICOS complex assembly and mitochondrial ultrastructure. This mutation leads to impaired processing and binding of the MIC26 protein to the inner mitochondrial membrane, resulting in alterations in MICOS assembly and affecting the distribution of the MICOS subunit MIC60 (Benincá2020Mutation). The expression of wild-type MIC26 in patient cells can restore the normal distribution of MIC60, highlighting the importance of balanced MIC26 levels for proper MICOS assembly (Benincá2020Mutation).


## References


[1. (Chen2024Apolipoprotein) Jin Chen, Jiarui Hu, Xin Guo, Yang Yang, Donglu Qin, Xiaoyu Tang, Zhijie Huang, Fengjiao Wang, Die Hu, Daoquan Peng, and Bilian Yu. Apolipoprotein o modulates cholesterol metabolism via nrf2/cyb5r3 independent of ldl receptor. Cell Death &amp; Disease, June 2024. URL: http://dx.doi.org/10.1038/s41419-024-06778-4, doi:10.1038/s41419-024-06778-4. This article has 0 citations.](https://doi.org/10.1038/s41419-024-06778-4)

[2. (Lamant2006ApoO) Matthieu Lamant, Fatima Smih, Romain Harmancey, Pierre Philip-Couderc, Atul Pathak, Jerome Roncalli, Michel Galinier, Xavier Collet, Pierre Massabuau, Jean-Michel Senard, and Philippe Rouet. Apoo, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart. Journal of Biological Chemistry, 281(47):36289–36302, November 2006. URL: http://dx.doi.org/10.1074/jbc.m510861200, doi:10.1074/jbc.m510861200. This article has 68 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m510861200)

[3. (Turkieh2014Apolipoprotein) Annie Turkieh, Céline Caubère, Manon Barutaut, Franck Desmoulin, Romain Harmancey, Michel Galinier, Matthieu Berry, Camille Dambrin, Carlo Polidori, Louis Casteilla, François Koukoui, Philippe Rouet, and Fatima Smih. Apolipoprotein o is mitochondrial and promotes lipotoxicity in heart. Journal of Clinical Investigation, 124(5):2277–2286, April 2014. URL: http://dx.doi.org/10.1172/jci74668, doi:10.1172/jci74668. This article has 46 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci74668)

[4. (Benincá2020Mutation) Cristiane Benincá, Vanessa Zanette, Michele Brischigliaro, Mark Johnson, Aurelio Reyes, Daniel Almeida do Valle, Alan J. Robinson, Andrea Degiorgi, Anna Yeates, Bruno Augusto Telles, Julien Prudent, Enrico Baruffini, Mara Lucia S. F. Santos, Ricardo Lehtonen R. de Souza, Erika Fernandez-Vizarra, Alexander J. Whitworth, and Massimo Zeviani. Mutation in the micos subunit gene apoo (mic26) associated with an x-linked recessive mitochondrial myopathy, lactic acidosis, cognitive impairment and autistic features. Journal of Medical Genetics, 58(3):155–167, May 2020. URL: http://dx.doi.org/10.1136/jmedgenet-2020-106861, doi:10.1136/jmedgenet-2020-106861. This article has 30 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmedgenet-2020-106861)

[5. (Weijler2018Oleic) Anna M. Weijler, Barbara Schmidinger, Stylianos Kapiotis, Hilde Laggner, and Marcela Hermann. Oleic acid induces the novel apolipoprotein o and reduces mitochondrial membrane potential in chicken and human hepatoma cells. Biochimie, 147:136–142, April 2018. URL: http://dx.doi.org/10.1016/j.biochi.2018.02.003, doi:10.1016/j.biochi.2018.02.003. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biochi.2018.02.003)

[6. (Koob2015The) Sebastian Koob, Miguel Barrera, Ruchika Anand, and Andreas S. Reichert. The non-glycosylated isoform of mic26 is a constituent of the mammalian micos complex and promotes formation of crista junctions. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1853(7):1551–1563, July 2015. URL: http://dx.doi.org/10.1016/j.bbamcr.2015.03.004, doi:10.1016/j.bbamcr.2015.03.004. This article has 67 citations.](https://doi.org/10.1016/j.bbamcr.2015.03.004)